Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF THE CHINESE ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Huangqi
English: Baikal Skullcap
Latin: Scutellaria baicalensis Georgi

Sources:The rooots of Scutellaria baicalensis Georgi Family Labiatae.

Constituents: Containing baicalin, wogonosifr, wogonin, flavone,etc.

Actions:
The tests in vivo, showed that the alcohol and hot water extracts of the herb have inhibitory effect against S180, the inhibitory rates were 37.7% and 11.5% respectively. The inhibiting rate of hot water extract was 100% against JTC-26 cell line, but has strong inhibitory effect against normal cells in vitro. In addition, the water solution of the herb of 10ug/ml administered for 2 days, possessed cytotoxic effect to HL-60 cell line.

Indications:It was used for treatment of lung, nasoparyngeal, breast cancer and leukemia, etc.

(1)Composite prescription for treatment for acute leukemia:
Radix Scutellariae 10g
Fadix Gentianae 10g
Fructus Gardeniae 10g
Carlis Aristolochiae Manshuriensis 10g
Radix Angelicae Sinensis 10g
Radix Rehmanniae 10g
Radix Bupleuri 10g
Polyporus 10g
Rhizoma Alismatis 10g
Caulis Spatholobi 30g
Radix Saluiae Miltiorrhizae 30g

The decoction of above herbs was taken to treat 26 cases of acute leukemias. The results showed that CR and PR were 14 and 10 cases ,the total responsive rate was 92.3% and 13 cases survived over one year and 3 cases survived over 2 years.

(2) Man Xing Wan (pill) was used for chronic granulocytic leukemia. A pill of 3g containing:
Radix Scutellariae 0.3g
Radix Sophorae Flauescentis 0.3g
Cortex Phellodendri 0.3g
Realgar 0.3g
Radix Angelicae Sinensis 0.3g
Herba Violae 0.3g
Indigo Naturalis 0.3g
Fructus Chebulae 0.3g
Radix Ranunculi Ternati 0.3g
Eupolyphaga seu Steleophaga 0.15
Hirudo 0.15g

The pills were taken to treat 12 cases of chronic granulocytic leukemia with a dose of 4.5 to 9g (treating dosage) or 3 to 6g (maintaining dosage) daily. The results showed that CR, PR, improvement and ineffect were in 6 , 1, 4 and 1 cases respectively, the total responsive rate was 91.7%.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved